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Table 2
Antibotic susceptibility (according to CLSI guidelines)
S. aureus
(%
sensitive)
#Samples E. coli (%
sensitive)
#Samples K. pneu-
moniae(%
sensitive)
#Samples
Ampicillin 10% 19 0% 8
Augmentin 56% 9 71% 7
Ceftriaxone- 90% I0 57% 7
Chloramphenicol 72% 39 75 8 38% 8
Erythromycin 59% 39
Gentamicin 100% 37 70% 10 75% 8
Oﬂoxacin 100% 9 100% 5
Oﬂoxacin or methicillin 100% 25
Penicillin 6% 36
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Conclusion: A strong correlation existed between emm-
sequence type and bacteriophage-associated super-antigen genesCo-trimaoxazole 97% 31 10% 10 50% 8
Vancomycin 10% 19
ountries. Empiric treatment of neonatal sepsis should include an
gent active against S. aureus, such as cloxacillin with gentamicin
MRSA was not detected).
Alarmingly, we found a high frequency of E. coli resistant to
mpicillin. Antibiotic stewardship and hospital hygiene need to be
igh priorities [6].
Our data suggest a possible role for hot beds in neonatal S. aureus
acteremia.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.782
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Background: A dramatic reduction in the number of hospi-
alisations for acute rotavirus gastroenteritis has been observed
n Australian children following introduction of the rotavirus
mmunisation program in July 2007. This study aimed to assess
nd compare severity of hospitalised rotavirus gastroenteritis in
hildren prior to and following introduction of the rotavirus immu-
isation program.
Methods: Rotavirus gastroenteritis hospitalisations of chil-
ren<5 years of age at a tertiary paediatric hospital, during a
wo year period pre and post rotavirus vaccine introduction, were
eviewed and scored for severity using two internationally recog-
ised gastroenteritis severity scoring systems (Clark and Vesikari)
ll cases had laboratory conﬁrmed rotavirus infection. The sample
ize allowed for >90% power to detect a difference in mean severity
core of 1.5 units.
Results: A total of 203 hospitalisations prior to and 45 hospital-
sations post introduction of rotavirus vaccine were reviewed. Age
f children ranged from 10 days - 4 years 11 months. There were
ore males than females in both periods with 56% males overall
p =0.004). The mean age of children hospitalised was signiﬁ-
antly higher following introduction of the immunisation program
20.4 months prior compared to 32.7 months post introduction;
= <0.001). The mean Clark severity score was 10.8 (10.3-11.2)fectious Diseases 16S (2012) e158–e316 e203
prior to vaccine introduction and 10.4 (9.4-11.3) post introduction.
Similarly, the mean Vesikari scores were 13.5 (13.1-13.9) prior to
and 13.4 (12.3-14.4) post introduction of the rotavirus immunisa-
tion program. There was no signiﬁcant difference in proportions
of hospitalised cases scoring moderate-severe, between the pre
and post rotavirus immunisation periods for either severity scale
(Clark: 81% vs 79% and Vesikari: 88% vs 88%). The mean duration
of hospitalisation was 33.2hours (range: 2hours – 10.5 days), with
no signiﬁcant difference in length of stay prior to introduction of
the rotavirus immunisation program (32.3hours, range 5hrs – 10.5
days) compared to post introduction (37.6hrs, range 2hours - 5.6
days; p =0.24).
Conclusion: Rotavirus vaccines have been very successful in
reducing the number of paediatric hospitalisations due to acute
rotavirus gastroenteritis, however our ﬁndings suggest there has
been no impact on the severity of hospitalised cases. An increase
in the mean age at hospitalisation following introduction of the
rotavirus immunisation program was identiﬁed.
http://dx.doi.org/10.1016/j.ijid.2012.05.783
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Prevalence of bacteriophage-associated super-antigen genes in
Streptococcus pyogenes isolated from pediatric patients in Japan
M. Minami ∗, Y. Oshima, M. Kuriyama, T. Hasegawa
Nagoya City University, Nagoya, Japan
Background: Streptococcus pyogenes infection is one of themost
common in pediatric diseases. Lysogenic bacteriophage is included
in the genome of Streptococcus pyogenes. Although prophages com-
prise a small fraction of the Streptococcus pyogenes genome, they
may account for up to 70% of the variation in the gene makeup
of Streptococcus pyogenes. Streptococcal bacteriophage encodes
super- antigen genes that are widely considered to be virulent
factors. In this study, we tried to clarify the recent prevalence of
bacteriophage-associated super antigengenes in Streptococcus pyo-
genes isolated from pediatric patients in Japan.
Methods: We collected 143 clinical Streptococcus pyogenes iso-
lates from children at four medical facilities in Japan from 2009
to 2011. We investigated the presence of 7 known super-antigen
genes carried by prophage; speA, speC, speH, speI, speK, speL,and
speM by PCR methods. The emm types of Streptococcus pyogenes
strains were also determined by the sequencing of the emm gene.
Results: The prevalence of speA, speC, speH, speI, speK, speL and
speM genes were 30.1%, 61.5%, 20.3%, 31.4%, 16.1%, 18.2%, and 7.7%,
respectively. The 19 kinds of emm typeswere observed in 143 clini-
cal isolates. The threemajor emm types of 143 clinical isolateswere
M12, M1, and M89, respectively. The 92% of M1 strains possessed
speA. The 78% of M12 strains, 81% of M89 strains, and 87.5% of M4
strains possessed speC. The 50% of M12 strains possessed speH. The
78% of M12 strains and 75% of M75 strains possessed speI. The 75%
ofM4 strains possessed speK. AllM4 strains possessed speL. AllM75
strains possessed speM.in Streptococcus pyogenes. We suggested that substantial contribu-
